Third-Party Tested ≥98% HPLC Purity — USA Shipped

Research Comparison

HCG vs PT-141

In Short

HCG is glycoprotein gonadotropin (lh/cg receptor agonist); PT-141 is melanocortin receptor agonist (mc3r/mc4r). Both are supplied as lyophilized powders for laboratory and in-vitro research use only. The table below compares their molecular data, half-life and research focus side by side.

HCG PT-141
Classification Glycoprotein gonadotropin (LH/CG receptor agonist) Melanocortin receptor agonist (MC3R/MC4R)
Molecular formula C50H68N14O10
Molecular weight 1025.18 g/mol
CAS number 9002-61-3 189691-06-3
Research half-life Biphasic; approximately 6-12 hours initial and ~24-36 hours terminal in published human pharmacokinetic studies (long-acting relative to LH) ~2–3 hours in preclinical models
Primary research focus LH/hCG receptor signaling research Melanocortin MC3R/MC4R pathway research
Form Lyophilized powder Lyophilized powder
Price from $75.00 $42.00

HCG

Human chorionic gonadotropin is a glycoprotein hormone that mimics luteinizing hormone by binding the LH/hCG receptor on Leydig and granulosa cells. In research settings it is used as a tool to study steroidogenesis, gonadal function, and the hypothalamic-pituitary-gonadal axis, including models of testosterone production and ovulation induction pathways. Because of its long half-life and potent receptor activity, it is a common reference agonist in reproductive endocrinology research. Supplied as a lyophilized powder for in-vitro and laboratory research use only; not for human or veterinary use.

Full HCG research guide

PT-141

PT-141, also known as Bremelanotide, is a cyclic heptapeptide melanocortin receptor agonist derived from the alpha-melanocyte-stimulating hormone (alpha-MSH) analogue Melanotan II. Unlike PDE5 inhibitors that act on vascular smooth muscle, PT-141 operates centrally through melanocortin-4 receptor (MC4R) activation in the hypothalamus and limbic system, initiating downstream dopaminergic signaling pathways associated with arousal and sexual motivation. Phase III clinical trials conducted by Palatin Technologies and published in The Journal of Sexual Medicine demonstrated that PT-141 use produced statistically significant increases in satisfying sexual events and desire scores in premenopausal women with hypoactive sexual desire disorder (HSDD). Research by Diamond et al. (2006) in the International Journal of Impotence Research showed efficacy in male subjects who had not responded to PDE5 inhibitor therapy, suggesting a fundamentally different mechanism of action. Additional preclinical studies have identified potential roles in hemorrhagic shock models, where MC receptor activation provided protective effects on organ perfusion. Compared to sildenafil (Viagra) and tadalafil (Cialis), which are peripherally acting vasodilators, PT-141 is unique in its central nervous system mechanism. This distinction is significant because it suggests PT-141 may address desire-based dysfunction rather than purely mechanical melanocortin-pathway signaling. Melanotan II, its parent compound, activates multiple MC receptors non-selectively, while PT-141 shows preferential MC4R and MC1R activity. Store lyophilized PT-141 at -20°C. Reconstitute with bacteriostatic water and keep at 2-8°C, using within 4 weeks. PT-141 is investigated by sexual medicine researchers, neuroendocrinologists, and emergency medicine scientists studying melanocortin-based interventions.

Full PT-141 research guide

Frequently Asked Questions

What is the main difference between HCG and PT-141?
HCG is classified as glycoprotein gonadotropin (lh/cg receptor agonist), while PT-141 is melanocortin receptor agonist (mc3r/mc4r). They are distinct research compounds with different mechanisms — the comparison table above sets out the molecular and pharmacokinetic differences side by side.
Can HCG and PT-141 be studied together?
Some research protocols evaluate related peptides in combination, and research blends exist. Combination study design depends entirely on the research question and model. Both compounds are supplied for laboratory and in-vitro research use only — not for human use.
Are HCG and PT-141 legal to buy for research?
Both are sold in the United States as research chemicals for laboratory and in-vitro use only. Neither is FDA-approved for human use. Researchers are responsible for compliance with all applicable regulations.

Buy HCG

From $75.00 — ≥98% HPLC, COA included.

Buy PT-141

From $42.00 — ≥98% HPLC, COA included.

Research Use Only. This comparison summarizes published research. It is not medical advice. Neither compound is for human consumption or FDA-approved.